← Back to All Filings

iRhythm CFO Sells $1.66M in Stock Under 10b5-1 Plan

Low SignificanceNovember 3, 2025 at 4:31:55 PM EST

iRhythm Technologies, Inc.

$IRTC4CIK: 0001388658

Subscribe to track IRTC

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

iRhythm CFO Sells $1.66M in Stock Under 10b5-1 Plan

Company: iRhythm Technologies, Inc. (IRTC) Form: 4 | Filed: 2025-11-03 Significance: Low

Insider: Wilson Daniel G. Title: Chief Financial Officer | Relationship: Officer

Transaction: • Type: Sale • Shares: 8,000 • Price: $207.44 • Value: $1,659,520 • Owned After: 26,570

Key Insight: The CFO sold shares valued at $1.66M, representing a very small percentage (0.0275%) of the company's market cap. The sale was pre-scheduled under a 10b5-1 plan, reducing its signaling value.

Market Context: This is a routine, pre-planned transaction with low market impact for a company with a $6.03B market capitalization.

Comprehensive Analysis

SEC Filing Analysis: iRhythm Technologies, Inc. (IRTC)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Financial Officer conducted a pre-planned sale of $1.66 million in stock, a transaction with minimal financial impact on the company.
  • Market Impact: Neutral, as the sale is immaterial relative to the company's market capitalization and was executed under a Rule 10b5-1 plan.

Company Information

FieldValue
CompanyiRhythm Technologies, Inc.
Ticker SymbolIRTC
CIK0001388658
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NameWilson Daniel G.
CIK0001860745
Title/PositionChief Financial Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-10-31
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved8,000
Price Per Share$207.44
Total Value$1,659,520
Shares Owned After26,570 (26,470 direct, 100 indirect)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,659,520
% of Market Cap0.0275%
Shares Transacted8,000
% of Shares Outstanding0.0249%
Post-Transaction Ownership26,570 shares (0.083% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $1.66 million transaction is negligible for iRhythm Technologies, a company with a market capitalization of $6.03 billion.
  • Ownership Concentration: The CFO's post-sale ownership of 0.083% is not a significant stake in the company.
  • Transaction Significance: The sale represents a very small fraction of both the company's market cap and its total shares outstanding, confirming its low significance. The sale constituted approximately 23% of the insider's direct holdings.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction's small size relative to the company's market scale and its pre-scheduled nature under a 10b5-1 plan suggest it is likely motivated by personal financial management rather than a change in the insider's outlook on the company.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The transaction size is too small to have a noticeable impact on daily trading volume.
  • Sentiment Indicator: Neutral. Pre-planned sales by executives are common and typically do not influence market sentiment.

Additional Context

Special Circumstances

  • This sale was executed under a Rule 10b5-1 trading plan, which was established by the reporting person on November 14, 2024. This indicates the trade was pre-scheduled, significantly reducing its value as a real-time market signal.
Topics:#SECFiling#InsiderTrading#IRTC#iRhythm#Form4#InsiderSell#CFO#StockMarket#Investing#10b51

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.